Ticker LaunchSPAC · Merger completed
Denali Capital Acquisition Corp.
Business combination with Semnur Pharmaceuticals, Inc.
Denali Capital Acquisition Corp. is a blank-check company (SPAC). It completed its business combination with Semnur Pharmaceuticals, Inc. on Sep 22, 2025; the combined company is Semnur Pharmaceuticals, Inc. (SMNR).
Semnur Pharmaceuticals is a clinical-late stage specialty pharmaceutical company focused on developing and commercializing novel non-opioid therapies for pain. It is the target of a proposed business combination with a special purpose acquisition company listed on Nasdaq as DECA.
- Status
- Merger completed
- Target
- Semnur Pharmaceuticals, Inc. (Legacy Semnur)
- Announced
- Sep 5, 2024
- Closed
- Sep 22, 2025
- Combined company
- Semnur Pharmaceuticals, Inc. (SMNR)
More on this SPAC for subscribers
- Shareholder vote date
- Merger proxy, registration statement and investor presentation
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Deal announcement (8-K) Sep 5, 2024
- Press release
- All filings on EDGAR CIK 1913577
Other deSPACs that closed in 2025
- Fusemachines Inc.via Consilium Acquisition Corp I, Ltd. (CSLM Acquisition Corp.) · closed Oct 22, 2025
- Terra Innovatum Global N.V.via GSR III Acquisition Corp. · closed Oct 9, 2025
- CN Healthy Food Tech Group Corp.via Iron Horse Acquisitions Corp. · closed Sep 30, 2025
- Kodiak AI, Inc.via Ares Acquisition Corporation II · closed Sep 24, 2025
- Angel Studios, Inc.via Southport Acquisition Corp · closed Sep 10, 2025
- YD Bio Limitedvia Breeze Holdings Acquisition Corp. · closed Aug 28, 2025